Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Teply

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|July 16, 2021
Current Management of Refractory Germ Cell TumorsOmar Abughanimeh, Benjamin A Teply
Cancers|November 27, 2021
Biomarkers for Treatment Response in Advanced Prostate CancerSamia Asif, Benjamin A Teply
Expert Review of Clinical Pharmacology|October 26, 2022
The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinationsBenjamin A Teply, Emmanuel S Antonarakis
Journal of Solid Tumors|November 19, 2014
Systemic therapy for bladder cancer - a medical oncologist's perspectiveBenjamin A Teply, Jenny J Kim
Current Opinion in Endocrinology, Diabetes, and Obesity|March 16, 2016
Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancerBenjamin A Teply, Emmanuel S Antonarakis
Expert Review of Clinical Pharmacology|June 3, 2017
Treatment strategies for DNA repair-deficient prostate cancerBenjamin A Teply, Emmanuel S Antonarakis
Oncology (Williston Park, N.Y.)|November 12, 2014
Identification and management of toxicities from immune checkpoint-blocking drugsBenjamin A Teply, Evan J Lipson
Indian Journal of Urology : IJU : Journal of the Urological Society of India|November 16, 2016
Chemotherapy options in castration-resistant prostate cancerBenjamin A Teply, Ralph J Hauke
The Prostate|March 27, 2023
A case of metastatic adenoid cystic (basal cell) carcinoma of the prostate: Systemic therapy for a rare diseaseJonathan Q Trinh, Subodh M Lele, Benjamin A Teply
JCO Oncology Practice|August 5, 2021
Impact of Performance Status on Response and Survival Among Patients Receiving Checkpoint Inhibitors for Advanced Solid TumorsMridula Krishnan, Pooja Kasinath, Robin High, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|July 16, 2021
Current Management of Refractory Germ Cell TumorsOmar Abughanimeh, Benjamin A Teply
Cancers|November 27, 2021
Biomarkers for Treatment Response in Advanced Prostate CancerSamia Asif, Benjamin A Teply
Expert Review of Clinical Pharmacology|October 26, 2022
The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinationsBenjamin A Teply, Emmanuel S Antonarakis
Journal of Solid Tumors|November 19, 2014
Systemic therapy for bladder cancer - a medical oncologist's perspectiveBenjamin A Teply, Jenny J Kim
Current Opinion in Endocrinology, Diabetes, and Obesity|March 16, 2016
Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancerBenjamin A Teply, Emmanuel S Antonarakis
Expert Review of Clinical Pharmacology|June 3, 2017
Treatment strategies for DNA repair-deficient prostate cancerBenjamin A Teply, Emmanuel S Antonarakis
Oncology (Williston Park, N.Y.)|November 12, 2014
Identification and management of toxicities from immune checkpoint-blocking drugsBenjamin A Teply, Evan J Lipson
Indian Journal of Urology : IJU : Journal of the Urological Society of India|November 16, 2016
Chemotherapy options in castration-resistant prostate cancerBenjamin A Teply, Ralph J Hauke
The Prostate|March 27, 2023
A case of metastatic adenoid cystic (basal cell) carcinoma of the prostate: Systemic therapy for a rare diseaseJonathan Q Trinh, Subodh M Lele, Benjamin A Teply
JCO Oncology Practice|August 5, 2021
Impact of Performance Status on Response and Survival Among Patients Receiving Checkpoint Inhibitors for Advanced Solid TumorsMridula Krishnan, Pooja Kasinath, Robin High, et al.
Pageof 5